https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:33128 Wed 04 Sep 2019 10:06:08 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:33134 Tue 28 Aug 2018 13:03:51 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:33130 Tue 28 Aug 2018 12:56:59 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:29712 P = 0.831), ODI (OR, 1.00; 95% CI 0.52–1.92; P = 0.996), SF-12 PCS (OR, 1.09; 95% CI 0.58–2.04; P = 0.791), and EQ-5D (OR, 0.62; 95% CI 0.32–1.21; P = 0.164). Disease-specific subgroup analyses confirmed the results. Conclusions: The present data suggest that patients with pBP have comparable functional and health-related quality of life outcomes after surgery for LDH or LSS with those of patients with pLP.]]> Sat 24 Mar 2018 07:33:26 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:25901 Sat 24 Mar 2018 07:28:16 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:27346 Sat 24 Mar 2018 07:24:07 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:24334 18.4 seconds, respectively. Conclusion: The TUG test is a quick, easy-to-use, valid, and reliable tool to evaluate objective functional impairment in patients with lumbar degenerative disc disease. In the clinical setting, patients scoring a TUG test time of over 12 seconds can be considered to have functional impairment.]]> Sat 24 Mar 2018 07:16:37 AEDT ]]>